Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xeris Biopharma Holdings (XERS) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to $18.4 million.

  • Xeris Biopharma Holdings' Cash from Operations rose 32193.86% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 13353.34%. This contributed to the annual value of -$37.0 million for FY2024, which is 2135.55% up from last year.
  • As of Q3 2025, Xeris Biopharma Holdings' Cash from Operations stood at $18.4 million, which was up 32193.86% from $182000.0 recorded in Q2 2025.
  • In the past 5 years, Xeris Biopharma Holdings' Cash from Operations registered a high of $18.4 million during Q3 2025, and its lowest value of -$48.4 million during Q1 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$16.1 million (2022), whereas its average is -$14.4 million.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Cash from Operations tumbled by 16631.7% in 2021 and then surged by 32193.86% in 2025.
  • Quarter analysis of 5 years shows Xeris Biopharma Holdings' Cash from Operations stood at -$28.9 million in 2021, then surged by 44.31% to -$16.1 million in 2022, then surged by 146.35% to $7.5 million in 2023, then crashed by 73.56% to $2.0 million in 2024, then soared by 833.27% to $18.4 million in 2025.
  • Its Cash from Operations was $18.4 million in Q3 2025, compared to $182000.0 in Q2 2025 and -$10.0 million in Q1 2025.